IP Verse

Krka patent opposition analysis

Get complete Patent Opposition Report for Krka

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Krka

Explore patent oppositions filed by Krka against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 8, 2023
EP3113774	Compositions Of Grapiprant And Methods For Using The Same	ARATANA THERAPEUTICS	Sep 21, 2022
EP2922526	Manufacturing Of Semi-Plastic Pharmaceutical Dosage Units	INTERVET	Jul 26, 2022
EP2863895	Tablet Formulation Comprising A Peptide And A Delivery Agent	NOVO NORDISK	Jan 14, 2022
EP3173071	Maropitant Formulation	LE VET	Dec 23, 2021
EP2478907	Methods And Compositions For Treating Cancer	COUGAR BIOTECHNOLOGY	Dec 22, 2021
EP3061454	Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Dec 9, 2021
EP2925324	Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia	RICHTER GEDEON NYRT	Sep 30, 2021
EP2340828	Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor	NOVARTIS	Apr 15, 2021
EP3215130	Pharmaceutical Composition Comprising Bisoprolol And Perindoril	LES LABORATOIRES SERVIER	Apr 8, 2021

Latest patents of Krka opposed by its competitors

Explore Krka's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2588090	Nov 22, 2023	Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts	6
EP3309158	Mar 16, 2022	Crystalline Form K Of Rivaroxaban And Process For Its Preparation	1
EP2459555	Nov 3, 2021	Processes For Crystallization Of Rivaroxaban	1
EP2585051	Apr 8, 2020	Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts	2

Top competitors of Krka

MUNDIPHARMA

NOVARTIS

BRISTOL MYERS SQUIBB IRELAND